Related Experiment Video
Updated: Jun 25, 2025

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
Validation of a PHIS Esophageal Atresia and Tracheoesophageal Fistula Cohort in ICD-10
Claire M Lawlor1, Ali Kamran2, John Bennett2
1Department of Otolaryngology, Children's National Health System, Washington, District of Columbia, USA.
Insights
This study validates a search method for identifying congenital esophageal atresia/tracheoesophageal atresia (EA/TEF) patients in the Pediatric Health Information System (PHIS) database. The validated method ensures accurate multi-institutional studies for rare diseases like EA/TEF.
Area of Science:
- Pediatric Surgery
- Health Informatics
- Rare Disease Research
Background:
- Congenital esophageal atresia/tracheoesophageal atresia (EA/TEF) is a rare condition requiring accurate patient identification for research.
- The Pediatric Health Information System (PHIS) database is a valuable resource for multi-institutional studies.
- Validating International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes is crucial for cohort accuracy.
Purpose of the Study:
- To validate a contemporary ICD-10-CM cohort for congenital EA/TEF in the PHIS database.
- To establish a high-fidelity patient cohort for multi-institutional research on EA/TEF.
- To demonstrate the utility of clinical databases for validating PHIS cohorts.
Main Methods:
- Database study involving modification of existing search methods for ICD-10-CM.
- Comparison of PHIS data against a single high-volume EA/TEF center's clinical database (October 2015 - July 2022).
- Progressive cohort refinement using diagnosis codes, inclusion of specific conditions, and procedure codes.
Main Results:
- The refined search yielded 93 patients in PHIS and 84 in the clinical database.
- High accuracy was achieved with 99% sensitivity and 94% positive predictive value.
- The validated method identified a cohort of 2479 EA/TEF patients across 49 children's hospitals.
Conclusions:
- A validated search method for identifying EA/TEF patients in PHIS has been established.
- Clinical databases are effective for validating PHIS-based cohorts.
- This methodology enables improved studies on practice variability and outcomes for EA/TEF and other rare diseases.
Objective:
Validation of a contemporary International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) congenital esophageal atresia/tracheoesophageal atresia (EA/TEF) cohort in the Pediatric Health Information System (PHIS) database.
Study Design:
Database study, validation.
Setting:
Tertiary care center.
Methods:
Search methods used to validate an ICD-9-CM EA/TEF cohort in PHIS were modified for ICD-10-CM. A retrospectively and prospectively maintained clinical database at a single high-volume EA/TEF center was used for comparison. Patients treated between October 1, 2015 and July 31, 2022 were included. Searches progressively narrowed the cohort by ICD-10-CM diagnosis codes, expansion to include incorrectly coded as 'iatrogenic, age less than 30 days, and use of at least 1 ICD-10-CM procedure code. Results of PHIS data and institution data were compared for accuracy.
Results:
The most refined search of PHIS and the EA/TEF clinical database yielded 93 and 84 patients, respectively. The sensitivity was 99% and positive predictive value was 94%. A PHIS search using these methods and encompassing 49 children's hospitals yielded an EA/TEF cohort of 2479 patients.
Conclusion:
We present a validated search method in the PHIS database to identify a high-fidelity cohort of EA/TEF patients for multi-institutional study. We have demonstrated that a carefully maintained clinical database may be used to validate cohorts in PHIS. This cohort allows for improved practice variability and outcomes study of EA/TEF patients. Similar methods may be employed to generate other rare disease cohorts in PHIS.
Level Of Evidence:
Level 4.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

